|
News
RTOG-NSABP Alliance Press Release
3-4-2011
BETH (B-44-I)
International Press Release: First patient enrolled in global phase III study of
bevacizumab and trastuzumab in early breast cancer (Tuesday, May 27, 2008)
NSABP Bibliography of
Peer-Reviewed Journal Publications
NSABP Pathology Laboratory Grand Opening (October 2006)
Results and Overview of the Study of Tamoxifen and
Raloxifene (Star/P-2), the NSABP's Second Breast Cancer Prevention Trial (April
2006)
Ground-Breaking Study by the NSABP
Demonstrates Novel Way to Use Common Cancer Gene (called cMYC) to Trigger Death
of Breast Cancer Cells (December 2005)
|
